Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$1.4 - $25.4 $2 - $50
2 Added 200.0%
3 $0
Q3 2022

Nov 14, 2022

SELL
$0.36 - $36.0 $282 - $28,224
-784 Reduced 99.87%
1 $1,000
Q2 2022

Aug 15, 2022

BUY
$12.3 - $27.3 $9,655 - $21,430
785 New
785 $2,000
Q3 2019

Nov 14, 2019

SELL
$6.7 - $11.8 $111,467 - $196,316
-16,637 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
N/A
-7,104,349 Reduced 99.77%
16,637 $0
Q3 2018

Nov 13, 2018

BUY
N/A
7,120,986 New
7,120,986 $56.7 Million

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.